article thumbnail

Primary Care Provider Perspectives at an Academic Medical Center: Are Telemedicine Visits as Effective as In-person Care? [Survey research or cross-sectional study]

Annals of Family Medicine

Context: As academic medical centers purposefully integrate telemedicine visits into primary care, efficacy studies are needed to appropriately guide resource allocation and triage processes. Setting: Providers across six Northern California clinic sites surveyed over an 8-week period (March 21-May 16, 2023).

article thumbnail

New research in finds telemedicine consistently outperforms in-person visits for cancer care when both are available

Medical Xpress

New research in the May 2023 issue of the Journal of the National Comprehensive Cancer Network from Moffitt Cancer Center finds that telemedicine consistently outperformed in-person visits for both access to care and provider response, according to a long-term study on patient experience.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

JOIN HP&M FOR A WEBINAR: “The ‘End’ of the COVID-19 Emergency: The Ryan Haight Act, Telemedicine, and Next Steps?” on Thursday, March 23, 2023 at 12 Noon EST

FDA Law Blog

When the public health emergency ends on May 11, 2023 , so do these exemptions. We will discuss the state of relevant laws prior to our new “COVID reality” and telemedicine issues during and post-pandemic, both with respect to the prescribing of controlled substances and non-controlled drugs. Hyman, Phelps & McNamara, P.C.’s

article thumbnail

CONTINUED AGAIN: DEA Announces A Second Extension of its “Temporary Rule” Addressing Telemedicine Flexibilities After the End of the COVID-19 Pandemic Emergency

FDA Law Blog

Palmer — On Friday, October 6, 2023, DEA announced a second extension of telemedicine flexibilities concerning the prescribing of controlled substances, which were originally set to expire after the end of the COVID-19 pandemic emergency. By Karla L. DEA received a whopping 38,000 (!) comments on the two proposed rules.

article thumbnail

May 11, 2023: The End of the COVID-19 Pandemic Emergency’s DEA Telemedicine Exemption? “Not So Fast,” Say DEA and SAMHSA

FDA Law Blog

Palmer — We blogged earlier this week here that DEA is reconsidering its proposed rules for telemedicine prescribing of controlled substances and buprenorphine. 30,038 (May 10, 2023). 802(54)(G) (which references CMS’s statutory definition of “practice of telemedicine”). . § 1307.41and 42 C.F.R.

article thumbnail

Early Prevention of Critical Illness in Older Adults: Adaptation and Pilot Testing of an Electronic Risk Score and Checklist [Geriatrics]

Annals of Family Medicine

Study Design and Analysis: The ERA score and CERTAIN-FM checklist were implemented between May and July 2023 to identify and assess all patients age ≥60 years at risk of critical illness during their primary care visits. Intervention/Instrument: Elders Risk Assessment (ERA) index and CERTAIN-FM.

Illness 130
article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

FDA Law Blog

Palmer — The 2008 Ryan Haight Online Pharmacy Consumer Protection Act placed strict limits on online prescribing or the use of telemedicine encounters to prescribe controlled substances. The Act also established new definitions for “Internet,” “online pharmacy,” “practice of telemedicine,” among others. By Karla L. 21 U.S.C. §